IBM profit up 9%; revenue rises
- January 20, 2010
IBM Corp. said Tuesday that it managed a 9% increase in profit in the last quarter as its revenue grew for the first time in a year and a half. The ... Read More
IBM Corp. said Tuesday that it managed a 9% increase in profit in the last quarter as its revenue grew for the first time in a year and a half. The ... Read More
South Korea’s top automaker Hyundai Motor said on Feb. 3 that its U.S. sales jumped by almost a quarter last month, as Japanese rival Toyota grappled with a massive recall. Hyundai ... Read More
Hospira Inc. said Tuesday the Food and Drug Administration has approved its generic version of AstraZeneca’s antibiotic Merrem. The FDA cleared Hospira’s version of intravenous meropenem in 500-milligram and 1-gram vials. ... Read More
Honda said on July 20 that it would roll out an electric car and plug-in hybrids in Japan and the United States in 2012 as it tries to catch up in ... Read More
Hitachi Ltd. said Monday it will invest 1 trillion yen ($11 billion), or about 70% of its capital expenditure over the next three years, on its “social innovation” businesses, which include ... Read More
Hefty-brand trash bag maker Pactiv Corp. has bought a leading producer of disposable food containers, PWP Industries, for $200 million. Pactiv, a consumer packaging maker, said on Tuesday it expected the ... Read More
Hewlett-Packard Co. has agreed to acquire Palm for $1.4 billion in cash, uniting a pair of companies that have failed to make much recent headway in the smart phone business. H-P ... Read More
Handmark Inc. is helping Freedom Communications Inc. develop mobile device applications for its group of newspapers and television stations. The Kansas City-based software company said in a release Tuesday that it ... Read More
Colorado’s Global Med Technologies Inc., a medical-information technology company, has agreed to be bought by Haemonetics Corp. in a deal worth $60 million for shareholders. Braintree, Mass.-based Haemonetics has offered to ... Read More
Grifols SA of Spain plans to buy Talecris Biotherapeutics Holdings Corp., a U.S. maker of plasma medicines part-owned by Cerberus Capital Management LP, for more than $3 billion, according to people ... Read More